Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Erlotinib plus anlotinib shows promise in EGFR-mutated NSCLC

Feb. 4, 2021

ABTL-0812 plus paclitaxel and carboplatin result in increased efficacy in NSCLC

Feb. 4, 2021

RCC-33 reduces tumor volume in mice inoculated with colorectal cancer cells

Feb. 4, 2021

Phase Ib data show lack of objective response for CMP-001 plus atezolizumab in NSCLC

Feb. 4, 2021

Novartis discovers AKR1C3-dependent GTPase KRAS inhibitors

Feb. 4, 2021

Cybrexa 3 patents peptide conjugates of microtubule-targeting agents

Feb. 4, 2021

New cannabinoid CB1 and CB2 receptor ligands identified at Canopy Growth Corp.

Feb. 4, 2021

DexTech expands preclinical program to evaluate OsteoDex in multiple myeloma

Feb. 3, 2021

Curis initiates phase II LUCAS study of CA-4948 as treatment for anemia in MDS

Feb. 3, 2021

Phase I data presented for AXL inhibitor DS-1205c plus osimertinib in EGFR-mutated NSCLC

Feb. 3, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...